ALERT: COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patient’s protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine visits are available for routine office visits.

All Patients – Very Important: Regardless of vaccination status.  If you are experiencing a fever or cold-like like symptoms, which also include GI Symptoms and Diarrhea, you should contact your Virginia Cancer Specialists Advice Line before visiting our clinics for scheduled appointments. This includes symptoms of respiratory illness, such as coughing or difficulty breathing.  More Information-PLEASE CLICK HERE

Immunotherapy Cancer Treatment - Exciting new area for oncology

Virginia Cancer Specialists Practice Blog

August 29, 2016
Virginia Cancer Specialists » VCS Practice News » Clinical Trials and Research » VCS Practice News » The Research Institute » Immunotherapy Cancer Treatment – Exciting new area for oncology

Immunotherapy has proven to be one of the most exciting new areas for oncology and for our patients.

These drugs have proven to be very effective in certain cancers (e.g. melanoma, lung cancer) but not in all. VCS is excited to open several new clinical trials using immunotherapy for patients that have either failed prior immunotherapy drugs or are interested in this approach for their cancers.

Currently we have several studies open across many tumor types using this approach.

In addition, we have other studies as well at other novel therapeutics as well for patients looking to explore treatments different than the standard, or looking for alternatives to standard chemotherapy. VCS currently runs a Phase 1 clinic with access to physicians with expertise in novel therapeutics, clinical trials, and personalized/genomic approaches to their care.

Alex Spira, MD, PhD, FACP

Alex Spira, M.D., PhD, F.A.C.P.

Clinical Trials and Research at Virginia Cancer Specialists



Schedule An Appointment Here